Literature DB >> 27891330

Evaluation of Lipid Profile and Apolipoproteins in Essential Hypertensive Patients.

Parsuram Nayak1, Suchismita Panda2, Pravat Kumar Thatoi3, Roma Rattan2, Srikrushna Mohapatra4, Pramila Kumari Mishra5.   

Abstract

INTRODUCTION: Essential hypertension is one of the most common diseases of the Indian population contributing greatly to the morbidity, mortality and economic burden. It has a strong association with cardiovascular disease and abnormal lipid metabolism. Not only the traditional lipid parameters, but also the novel lipid components like Apo A1 and Apo B100 also have been identified to play a role. AIM: The present study was done to evaluate serum lipid profile and Apo A1, Apo B 100 in essential hypertensive patients and correlate their values with the degree of hypertension.
MATERIALS AND METHODS: Fasting samples from 55 age and sex matched controls and 55 essential hypertensives were tested for plasma glucose, serum urea, creatinine, lipid profile, apo A1 and apo B100. The cases were subclassified based on the severity of hypertension according to JNC criteria.
RESULTS: The study showed a significantly raised value for serum cholesterol, triacylglycerol, Low Density Lipoprotein (LDL), Very Low-Density Lipoprotein (VLDL) in the hypertensive patients than the control group whereas serum High-Density Lipoprotein (HDL) registered a fall in the cases. Apo A1 revealed a non-significant fall in the hypertensive patients. In contrast, there was a rise in the serum apo B100 in the cases. Apo B100/apo A1 ratio was significantly raised in both stage I and stage II hypertensive patients in comparision to the controls. When correlated, serum apo A1 revealed a negative association where as serum apo B 100 showed a positive association with systolic and diastolic bloood pressure. Both LDL/HDL and apoB100/apo A1 and apo B100 revealed a significant positive association with both SBP and DBP. However, apoB100/apo A1 revealed a more positive association in comparision to LDL/HDL ratio (r=0.749, p<0.001, r=0.756, p<0.001 vs r=0.336, p<0.000, r=0.312, p<0.001).
CONCLUSION: Apo B100/apoA1 has emerged as an important complementary parameter in addition to traditional lipid ratio for evaluation of risk for future cardiovascular disease.

Entities:  

Keywords:  Atherosclerosis; Coronary heart disease; Dyslipidemia

Year:  2016        PMID: 27891330      PMCID: PMC5121668          DOI: 10.7860/JCDR/2016/20985.8626

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  29 in total

1.  Concordance for dyslipidemic hypertension in male twins.

Authors:  J V Selby; B Newman; J Quiroga; J C Christian; M A Austin; R R Fabsitz
Journal:  JAMA       Date:  1991-04-24       Impact factor: 56.272

2.  Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study.

Authors:  Christa Meisinger; Hannelore Loewel; Wilfried Mraz; Wolfgang Koenig
Journal:  Eur Heart J       Date:  2004-11-30       Impact factor: 29.983

3.  Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.

Authors:  A D Sniderman; I Jungner; I Junger; I Holme; A Aastveit; G Walldius
Journal:  J Intern Med       Date:  2006-05       Impact factor: 8.989

Review 4.  Apo B/apo A-I ratio and cardiovascular risk prediction.

Authors:  Luciana Moreira Lima; Maria das Graças Carvalho; Marinez Oliveira Sousa
Journal:  Arq Bras Cardiol       Date:  2007-06       Impact factor: 2.000

5.  High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.

Authors:  G Walldius; I Jungner; I Holme; A H Aastveit; W Kolar; E Steiner
Journal:  Lancet       Date:  2001-12-15       Impact factor: 79.321

6.  Introduction to the geographic pathology of atherosclerosis.

Authors:  H C McGill
Journal:  Lab Invest       Date:  1968-05       Impact factor: 5.662

7.  Longitudinal trajectories of arterial stiffness and the role of blood pressure: the Baltimore Longitudinal Study of Aging.

Authors:  Majd AlGhatrif; James B Strait; Chris H Morrell; Marco Canepa; Jeanette Wright; Palchamy Elango; Angelo Scuteri; Samer S Najjar; Luigi Ferrucci; Edward G Lakatta
Journal:  Hypertension       Date:  2013-09-03       Impact factor: 10.190

8.  International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of International Reference Material.

Authors:  S M Marcovina; J J Albers; H Kennedy; J V Mei; L O Henderson; W H Hannon
Journal:  Clin Chem       Date:  1994-04       Impact factor: 8.327

9.  Prevention of cardiovascular diseases: Role of exercise, dietary interventions, obesity and smoking cessation.

Authors:  Harpal S Buttar; Timao Li; Nivedita Ravi
Journal:  Exp Clin Cardiol       Date:  2005

Review 10.  Interactions between hypercholesterolemia and hypertension: implications for therapy.

Authors:  Claudio Borghi
Journal:  Curr Opin Nephrol Hypertens       Date:  2002-09       Impact factor: 2.894

View more
  4 in total

1.  N-(3-Benzoylphenyl)-1H-Indole-2-Carboxamide decreases triglyceride levels by downregulation of Apoc3 gene expression in acute hyperlipidemic rat model.

Authors:  Lama Hamadneh; Luay Al-Essa; Suhair Hikmat; Tariq Al-Qirim; Ghassan Abu Sheikha; Yusuf Al-Hiari; Nisrin Azmy; Ghassan Shattat
Journal:  Mol Cell Biochem       Date:  2017-03-02       Impact factor: 3.396

2.  Evaluation of lipid profiles and hematological parameters in hypertensive patients: Laboratory-based cross-sectional study.

Authors:  Alemu Gebrie; Natesan Gnanasekaran; Menakath Menon; Mekonnen Sisay; Abriham Zegeye
Journal:  SAGE Open Med       Date:  2018-02-12

3.  Juice from Fructus Rosae Roxburghii normalizes blood lipids in mice with diet-induced hyperlipidemia*.

Authors:  Pingping Song; Xiangchun Shen
Journal:  Food Sci Nutr       Date:  2020-09-18       Impact factor: 2.863

4.  Lipoprotein Particle Predictors of Arterial Stiffness after 17 Years of Follow Up: The Malmö Diet and Cancer Study.

Authors:  Jacob Hartz; Ronald M Krauss; Mikael Göttsater; Olle Melander; Peter Nilsson; Michele Mietus-Snyder
Journal:  Int J Vasc Med       Date:  2020-04-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.